Cargando…

Prediction models for neutralization activity against emerging SARS-CoV-2 variants: A cross-sectional study

OBJECTIVE: Despite extensive vaccination campaigns to combat the coronavirus disease (COVID-19) pandemic, variants of concern, particularly the Omicron variant (B.1.1.529 or BA.1), may escape the antibodies elicited by vaccination against SARS-CoV-2. Therefore, this study aimed to evaluate 50% neutr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goto, Atsushi, Miyakawa, Kei, Nakayama, Izumi, Yagome, Susumu, Xu, Juan, Kaneko, Makoto, Ohtake, Norihisa, Kato, Hideaki, Ryo, Akihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126441/ https://www.ncbi.nlm.nih.gov/pubmed/37113226 http://dx.doi.org/10.3389/fmicb.2023.1126527

Ejemplares similares

Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay
por: Kato, Hideaki, et al.
Publicado: (2022)

Sustained Neutralizing Antibodies 6 Months Following Infection in 376 Japanese COVID-19 Survivors
por: Goto, Atsushi, et al.
Publicado: (2021)

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination
por: Kato, Hideaki, et al.
Publicado: (2022)

Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies
por: Kubo, Sousuke, et al.
Publicado: (2021)

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
por: Miyakawa, Kei, et al.
Publicado: (2021)

Molecular and Epidemiological Characterization of Emerging Immune-Escape Variants of SARS-CoV-2
por: Miyakawa, Kei, et al.
Publicado: (2022)

Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
por: Miyakawa, Kei, et al.
Publicado: (2020)

Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2022)

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2
por: Koyama, Takahiko, et al.
Publicado: (2022)

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection
por: Miyakawa, Kei, et al.
Publicado: (2021)

Prospective Clinical Evaluation of the Diagnostic Accuracy of a Highly Sensitive Rapid Antigen Test Using Silver Amplification Technology for Emerging SARS-CoV-2 Variants
por: Obata, Kazuaki, et al.
Publicado: (2022)

Characterization and Utilization of Disulfide-Bonded SARS-CoV-2 Receptor Binding Domain of Spike Protein Synthesized by Wheat Germ Cell-Free Production System
por: Yamaoka, Yutaro, et al.
Publicado: (2022)

Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion
por: Jeremiah, Sundararaj Stanleyraj, et al.
Publicado: (2021)

H11/HSPB8 Restricts HIV-2 Vpx to Restore the Anti-Viral Activity of SAMHD1
por: Kudoh, Ayumi, et al.
Publicado: (2016)

Potent antiviral effect of silver nanoparticles on SARS-CoV-2
por: Jeremiah, Sundararaj S., et al.
Publicado: (2020)

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
por: Uriu, Keiya, et al.
Publicado: (2021)

Longitudinal analysis of SARS-CoV-2 reinfection reveals distinct kinetics and emergence of cross-neutralizing antibodies to variants of concern
por: Facciuolo, Antonio, et al.
Publicado: (2023)

In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms
por: Lassaunière, Ria, et al.
Publicado: (2021)

Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
por: Miyakawa, Kei, et al.
Publicado: (2022)

Phosphopeptide enrichment using Phos-tag technology reveals functional phosphorylation of the nucleocapsid protein of SARS-CoV-2
por: Ino, Yoko, et al.
Publicado: (2022)

Influence of the COVID-19 Pandemic on Overall Physician Visits and Telemedicine Use Among Patients With Type 1 or Type 2 Diabetes in Japan
por: Yagome, Susumu, et al.
Publicado: (2022)

Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants
por: Li, Tingting, et al.
Publicado: (2022)

Molecular Evolution of the VP1 Gene in Human Norovirus GII.4 Variants in 1974–2015
por: Motoya, Takumi, et al.
Publicado: (2017)

Letter to the Editor in response to “Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavement”
por: Yagome, Susumu, et al.
Publicado: (2021)

Wheat germ cell-free system-based production of hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 for generation and characterization of monoclonal antibody
por: Matsunaga, Satoko, et al.
Publicado: (2014)

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses
por: Bajpai, Prashant, et al.
Publicado: (2022)

Pinning Down Viral Proteins: A New Prototype for Virus–Host Cell Interaction
por: Kojima, Yoshitsugu, et al.
Publicado: (2010)

Pathophysiology and epidemiology of virus-induced asthma
por: Kimura, Hirokazu, et al.
Publicado: (2014)

Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2
por: Castonguay, Nicolas, et al.
Publicado: (2021)

Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency
por: Markarian, Nathan M., et al.
Publicado: (2022)

Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro
por: Zapata-Cardona, María I., et al.
Publicado: (2022)

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant
por: Wen, Kun, et al.
Publicado: (2023)

Development of Monoclonal Antibodies and Antigen-Capture ELISA for Human Parechovirus Type 3
por: Goto, Keiko, et al.
Publicado: (2020)

Molecular Evolutionary Analyses of the RNA-Dependent RNA Polymerase Region in Norovirus Genogroup II
por: Ozaki, Keita, et al.
Publicado: (2018)

Eukaryotic Phytoplankton Contributing to a Seasonal Bloom and Carbon Export Revealed by Tracking Sequence Variants in the Western North Pacific
por: Shiozaki, Takuhei, et al.
Publicado: (2019)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
por: Morita, Takeshi, et al.
Publicado: (2021)

Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
por: Cho, Hyeseon, et al.
Publicado: (2021)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
por: Shrestha, Lok Bahadur, et al.
Publicado: (2021)

Editorial: Perspectives for the Next Generation of Virus Research: Spearheading the Use of Innovative Technologies and Methodologies
por: Yamamoto, Takatoki, et al.
Publicado: (2017)

A bivalent subunit vaccine efficiently produced in Pichia pastoris against SARS-CoV-2 and emerging variants
por: Xu, Huifang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a5bqo4c5cevlbbbudt24skcrc6